Survey of the prescription of step-2 analgesics in persons aged 75 years and older in general practitioners.

Geriatr Psychol Neuropsychiatr Vieil

Pôle personnes âgées, Hôpital de Champmaillot, CHU, Dijon, France, UMR Inserm/U1093 cognition, action, sensorimotor plasticité sensorimotrice, Université de Bourgogne Franche-Comté, UFR Staps, Dijon France.

Published: December 2017

Although step-2 analgesics (S2A) are recommended when step-1 analgesics (S1A) are ineffective or in cases of moderate to severe pain, their efficacy varies. This study evaluated the place attributed by general practitioners (GPs) to S2A in the treatment of nociceptive pain in elderly persons (EP). Descriptive, transversal and declarative study conducted among GPs in Burgundy. In total, 115 GPs took part in the survey. Among these, 60.8% had at least one consultation/day for pain. After paracetamol, which was systematically preferred, 56.4% prescribed S2A for EP. The reasons for prescribing S2A included pain not relieved by S1A in 93% of cases, another medical treatment or not (42.6%), or the existence of moderate to severe pain (31.3%). The use of S2A was more frequent in acute pain (79.1%) than in chronic pain (53%). Among GPs, 77.4% initially prescribed the minimal effective dose. GPs were reluctant to prescribe S2As for the following reasons: poor tolerance (78.3%) and the fear of severe adverse effects (57.4%). The most frequently cited adverse effects were nausea/vomiting and constipation by 66.1% of GPs. Nonetheless, 73.9% thought that S2As were necessary for EPs requiring outpatient care. Although the benefit/risk ration of S2As is controversial and their analgesic efficacy seems to be more variable than that of low-dose morphine, they have an important place in the therapeutic arsenal of GPs to treat pain in EP.

Download full-text PDF

Source
http://dx.doi.org/10.1684/pnv.2017.0694DOI Listing

Publication Analysis

Top Keywords

step-2 analgesics
8
general practitioners
8
moderate severe
8
pain
8
severe pain
8
adverse effects
8
gps
7
s2a
5
survey prescription
4
prescription step-2
4

Similar Publications

Article Synopsis
  • - Hemorrhage is the main cause of preventable death in trauma situations, leading to military and civilian advancements in medical practices, particularly through the use of tourniquets to manage extremity bleeding and save lives.
  • - While tourniquets have significantly decreased deaths from bleeding in military settings, noncompressible hemorrhage still poses a major risk, especially before patients receive definitive medical care.
  • - The study explores using a small, disposable pressure monitor during resuscitative endovascular balloon occlusion of the aorta (REBOA) to enhance blood pressure monitoring, facilitate better resuscitation practices, and reduce the need for blood products in extreme environments.
View Article and Find Full Text PDF

Gabapentin for Delirium in Infants in the Neonatal Intensive Care Unit.

J Pediatr Pharmacol Ther

October 2024

Department of Pharmacy: Clinical and Administrative Sciences (JLM, SBN, PNJ, AP), College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK.

Objective: A protocol was developed for neonatal intensive care unit (NICU) delirium: Step 1, gabapentin for pain or melatonin for sleep; Step 2, add on other Step 1 agent; Step 3, antipsychotics. The purpose of this study was to describe the utility and dosing of gabapentin for NICU delirium.

Methods: Retrospective evaluation of NICU patients from January 1, 2021-December 31, 2022 who received >1 dose of gabapentin based on the delirium protocol.

View Article and Find Full Text PDF

The WHO guidelines: the new and the old.

Curr Opin Support Palliat Care

December 2024

Supportive & Palliative Care, Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey, UK.

Purpose Of The Review: The original World Health Organisation (WHO) cancer pain guidelines were published in 1986 and used globally. Updated guidance was released in 2018. This review compares the 'old' with the 'new' with a closer look at the relevance of the WHO analgesic ladder in the current climate.

View Article and Find Full Text PDF

Effectiveness and safety of remimazolam combined with alfentanil in hysteroscopic examination: A prospective, randomized, single-blind trial.

Medicine (Baltimore)

April 2024

The Affiliated Nanhua Hospital, Department of Anesthesiology, Hengyang Medical School, University of Suth China, Hengyang, Hunan, China.

Background: Remimazolam is a novel, ultrashort-acting benzodiazepine. This study aimed to compare the efficacy and safety of remimazolam and propofol for hysteroscopic examination, to determine the optimal dose of remimazolam combined with alfentanil for painless hysteroscopy, and to calculate its median effective dose (ED50).

Methods: Step 1: A total of 208 patients undergoing hysteroscopic examination were prospectively included in this study.

View Article and Find Full Text PDF

Pharmacological pain therapy in cancer patients is based on guideline recommendations, which, however, do not fully coincide in all aspects due to varying weighting of evidence. The present article discusses current issues including the decreasing significance of the World Health Organization (WHO) analgesic ladder, with its distinction between step 2 and 3 being increasingly questioned. Risks of nonopioid analgesics such as paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs), particularly in older populations, are discussed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!